Rising Cases of Urinary Tract Infection Drive the Demand for Urinalysis Market

One of the key factors driving the market forward is the rising prevalence of urinary tract infections (UTIs) in developing countries. If left untreated, urinary tract infections (UTIs) can progress to the kidneys and cause birth complications in pregnant women, which is a significant factor driving market growth.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-urinalysis-market

Data Bridge Market Research analyses that the urinalysis market is expected to grow at a CAGR of 7.3% in the forecast period of 2020 to 2027 and is expected to reach USD 8,767.60 million by 2027.

The growing prevalence of chronic kidney diseases worldwide is expected to drive the market's growth rate

The prevalence of age-related illnesses such as diabetes, liver disease, and renal disease is expected to rise significantly as the senior population grows, accelerating the market's expansion.

Furthermore, the 13.3 million people worldwide who suffer from acute kidney injury (AKI) each year are at risk of developing CKD or renal failure in the coming years, which is expected to fuel market growth.

Report Scope and Market Segmentation

Segment Analysis:

Global urinalysis market is segmented into six notable segments which are based on the testing type, product, modality, application, end user and distribution channel.

• On the basis of testing type, global urinalysis market is segmented into urine biochemistry testing and urine sediment testing.

In 2020, the urine biochemistry testing segment is expected to dominate the urinalysis market

The urine biochemistry testing segment is expected to dominate the urinalysis market with 49.46% market share due to the growing advancement in the testing operations with the help of technology.

• On the basis of product, global urinalysis market is segmented into instruments and consumables. In 2020, the instruments segment is expected to dominate the urinalysis market with 49.46% market share due to the need for performing automatic accurate urine testing.
• On the basis of modality, global urinalysis market is segmented into portable, standlon, table top, bench top and others. In 2020, the portable segment is expected to dominate the urinalysis market with 49.46% market share due to the prevalence of urinary tract infections and the need to get the maximum relevant information with the help of modalities. 
• On the basis of application, global urinalysis market is segmented into urinary tract infections, kidney diseases, diabetes, liver diseases, pregnancy & fertility and others.

In 2020, the urinary tract infections segment is expected to dominate the urinalysis market

The urinary tract infections segment is expected to dominate the urinalysis market with 49.46% market share due to growing prevalence of urinary infections as it is considered as the most common outpatient infections with a life time incidence of more than 60% in adult women.

• On the basis of end-user, global urinalysis market is segmented into hospital, laboratory, homecare setting and others. In 2020, the hospital segment is expected to dominate the urinalysis market with 49.46% market share due to presence of trained professionals.
• On the basis of distribution channel segment, global urinalysis market is segmented into direct tenders and retail sales. In 2020, the direct tenders segment is expected to dominate the urinalysis market with 49.46% market share due to increased demand of advanced technologies and testing requirements in medical care for urinalysis operations and diagnosis.  

Major Players

Data Bridge Market Research recognizes the following companies as the major urinalysis market players in urinalysis market are Abbott (U.S.), Siemens (Germany), BD (U.S.), Thermo Fisher Scientific (U.S.), 77 Elektronika Kft (Hungary), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Beckman Coulter Inc. (U.S.), ACON Laboratories Inc. (U.S.), ARKRAY Inc. (Japan), Trinity Biotech (Ireland), Quidel Corporation (U.S.), ACON Laboratories Inc. (U.S.), Sysmex Corporation (Japan), Analyticon Biotechnologies Ag (Germany), Ekf Diagnostics (U.K.), Hti Medical Inc. (U.S.), Teco Diagnostics (U.S.), Tenko Medical System Corp (U.S.), Wama Diagnostica (Brazil)

Market Development

• In August 2020, Sysmex America, Inc. will have exclusive rights in North America to distribute and service Siemens Healthineers' CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.
• In December 2021, KDx Diagnostics, Inc., and Lister Hospital launched KDx's URO17 non-invasive urine test for diagnosis of bladder cancer in UK.

Regional Analysis

Geographically, the countries covered in the urinalysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

As per Data Bridge Market Research analysis:

North America is the dominant region in urinalysis market during the forecast period 2020 - 2027

In 2019, North America dominated the urinalysis market because of the increased use of urinalysis for the treatment of liver disease and urinary tract infections Furthermore, the growing number of Urinalysis patients will drive the region's urinalysis market growth during the forecast period.

Asia-Pacific is estimated to be the fastest-growing region in urinalysis market the forecast period 2020 - 2027

Asia-Pacific is expected to grow during the forecast period due to the rise in the initiatives taken by the government for the awareness related to the significance of diagnosis.

COVID-19 Impact Analysis

The COVID-19 pandemic had a significant impact on the urinalysis market. COVID-19 patients are more likely to suffer from acute kidney injury (AKI), which can result in serious health complications, including death. As a result, patients should consult with a nephrologist on a regular basis to avoid further health issues. Companies have made strategic decisions to carry out COVID-19 rapid tests, maintain revenues, and limit the impact of COVID-19 on their operating capabilities in the post-COVID scenario.

For more detailed information about the urinalysis market report, click here – https://www.databridgemarketresearch.com/reports/global-urinalysis-market